Zai Lab Ltd (NASDAQ:ZLAB)

161.29
Delayed Data
As of Apr 13
 +29.24 / +22.14%
Today’s Change
57.13
Today|||52-Week Range
193.54
+19.17%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$11.8B

Company Description

Zai Lab Ltd. is a biopharmaceutical company. It engages in the discovering, licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need in the fields of oncology, infectious, and autoimmune diseases. The firm's products include Zejula and Optune. The company was founded by Samantha Ying Du and Marietta Wu in April 2014 and is headquartered in Shanghai, China.

Contact Information

Zai Lab Ltd.
Jinchuang Plaza
Shanghai Shanghai 201210
P:862161632588
Investor Relations:
8613682576943

Employees

Shareholders

Mutual fund holders37.65%
Other institutional25.78%
Individual stakeholders--

Top Executives

Ying DuChairman & Chief Executive Officer
Tao FuPresident, Chief Operating Officer & Director
Billy ChoChief Financial Officer
Ning XuExecutive VP & Head-Clinical Operations
James YanChief Operating Officer-Research & Development